ArticleOncotarget2018

A pilot study of peptide vaccines for VEGF receptor 1 and 2 in patients with recurrent/progressive high grade glioma.

Shunsuke Shibao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.